CoChat

Selective anticancer agents suppress aging in Drosophila

Open access
Danilov, Anton, Shaposhnikov, Mikhail, Plyusnina, Ekaterina, Kogan, Valeria, Fedichev, Peter, Moskalev, Alexey · 2013 · Oncotarget
Cited by 45

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

// Anton Danilov 1 , Mikhail Shaposhnikov 1,2 , Ekaterina Plyusnina 1,2 , Valeria Kogan 3,4 , Peter Fedichev 3,4 and Alexey Moskalev 1,2,3 1 Institute of Biology, Komi Science Center, Russian Academy of Sciences, Syktyvkar, 167982, Russia 2 Syktyvkar State University, Syktyvkar, 167001, Russia 3 Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, 141700, Russia 4 Quantum Pharmaceuticals, Ul. Kosmonavta Volkova 6A-1205, Moscow, 125171, Russia Correspondence: Alexey Moskalev, email: // Keywords : longevity, quality of life, aging-suppressive substances, anticancer agents, PI3K, TOR, iNOS, NF-κB, Drosophila melanogaster Received : August 10, 2013 Accepted : September 6, 2013 Published : September 7, 2013 Abstract Mutations of the PI3K , TOR , iNOS , and NF-κB genes increase lifespan of model organisms and reduce the risk of some aging-associated diseases. We studied the effects of inhibitors of PI3K (wortmannin), TOR (rapamycin), iNOS (1400W), NF-κB (pyrrolidin dithiocarbamate and QNZ), and the combined effects of inhibitors: PI3K (wortmannin) and TOR (rapamycin), NF-κB (pyrrolidin dithiocarbamates) and PI3K (wortmannin), NF-κB (pyrrolidine dithiocarbamates) and TOR (rapamycin) on Drosophila melanogaster lifespan and quality of life (locomotor activity and fertility). Our data demonstrate that pharmacological inhibition of PI3K, TOR, NF-κB, and iNOS increases lifespan of Drosophila without decreasing quality of life. The greatest lifespan expanding effect was achieved by a combination of rapamycin (5 μM) and wortmannin (5 μM) (by 23.4%). The bioinformatic analysis (KEGG, REACTOME.PATH, DOLite, and GO.BP) showed the greatest aging-suppressor activity of rapamycin, consistent with experimental data.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.1272

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 45

Metadata

Authors
Danilov, A., Shaposhnikov, M., Plyusnina, E., Kogan, V., Fedichev, P., & Moskalev, A.
Venue
Oncotarget
Published
2013-09-07
Volume
4
Issue
9
Pages
1507-1526
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2101706908
Cited by
45
References
20
FWCI
1.47
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective anticancer agents suppress aging in Drosophila. https://app.cochat.ai/papers/10.18632/oncotarget.1272
The paper
Danilov, A., Shaposhnikov, M., Plyusnina, E., Kogan, V., Fedichev, P., & Moskalev, A. (2013). Selective anticancer agents suppress aging in Drosophila. Oncotarget. https://doi.org/10.18632/oncotarget.1272

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.